Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis. | Cell Genom | 2022 | 36778001 | PubTator, text mining | PubMed |
| Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption. | Curr Opin Toxicol | 2022 | 36777447 | PubTator, text mining | PubMed |
| Risk factors and management of hyperuricemia after renal transplantation. | Front Surg | 2022 | 36760666 | PubTator, text mining | PubMed |
| Preclinical species gene expression database: Development and meta-analysis. | Front Genet | 2022 | 36733943 | PubTator, text mining | PubMed |
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study. | Front Endocrinol (Lausanne) | 2022 | 36714585 | PubTator, text mining | PubMed |
| Drug-drug interactions of Integrase Strand Transfer Inhibitors among older people living with HIV: Interazioni farmacologiche degli inibitori delle integrase tra le persone anziane che vivono con HIV. | J HIV Ageing | 2022 | 36714525 | PubTator, text mining | PubMed |
| A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells. | Front Pharmacol | 2022 | 36712667 | PubTator, text mining | PubMed |
| Vericiguat: A New Hope for Heart Failure Patients. | Cardiovasc Ther | 2022 | 36618548 | PubTator, text mining | PubMed |
| Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. | Nutrients | 2022 | 36615808 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models. | Front Pharmacol | 2022 | 36582520 | PubTator, text mining | PubMed |
| Role of extracellular matrix components and structure in new renal models in vitro. | Front Physiol | 2022 | 36569770 | PubTator, text mining | PubMed |
| Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease. | Nat Commun | 2022 | 36564419 | PubTator, text mining | PubMed |
| Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review. | Toxicol Rep | 2022 | 36561952 | PubTator, text mining | PubMed |
| Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities. | Pharmaceutics | 2022 | 36559237 | PubTator, text mining | PubMed |
| Current Update on Transcellular Brain Drug Delivery. | Pharmaceutics | 2022 | 36559214 | PubTator, text mining | PubMed |
| Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in Human and Mouse Organic Cation Transporter OCT2. | Int J Mol Sci | 2022 | 36555439 | PubTator, text mining | PubMed |
| Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV. | Pharmacy (Basel) | 2022 | 36548320 | PubTator, text mining | PubMed |
| Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36544704 | PubTator, text mining | PubMed |
| Conference Proceedings - 6th International Conference on Molecular Diagnostics and Biomarker Discovery (MDBD 2022): Building Resilience in Biomedical Research : Penang, Malaysia. 11-13 October 2022. | BMC Proc | 2022 | 36544136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=15